PBC Science, Diagnostic Strategies, Optimal Treatment Timing and Burden of Disease

Oct 7, 2024

- Oct 6, 2025

0.5

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs) credit

Already have an Account? Log In
Don’t have an account? Register Today

Pre-Test

Complete the pre-quiz poll to access the course episodes.

Prequiz Podcast PBC Science, Diagnostic Strategies, Optimal Treatment Timing and Burden of Disease

1. Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease which is:

a. More Common in men

b. More Common in women

c. Most of the cases are reported in teenagers

d. More common in the middle-aged individuals (40-60 years of age)

e. b and d

2. Liver stiffness measurement with transient elastography (TE) or magnetic resonance elastography (MRE) can be used to risk stratify patients with PBC with the following cutoffs:

a. PBC patients with TE >10 Kpa or MRE >4.3 Kpa should be considered to have advanced fibrosis

b. PBC patients with TE >8 and MRE >2 Kpa should be considered to have advanced fibrosis

c. TE and MRI cannot be used in PBC because of lack of data

d. Liver biopsy is the only way to risk stratify these patients

course Faculty

Professor David Jones, OBE

Andreas Kremer, MD, PhD

Zobair Younossi, MD

Related Courses

Oncology

ASH2025 Update on Management of Anemia in Patients with Myelofibrosis

Dermatology

Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists

Rheumatology

The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patient...

Course Catalog

By Category

By Course Type

About AcademicCME

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs) credit

Pre-Test

course Faculty

Related Courses

© 2024 AcademicCME. All rights reserved.